# Piramal Pharma Limited, Pithampur, India – FDA Inspections

Source: https://www.keypedia.com/companies/piramal-pharma-limited/b492136d-42a5-47e3-a443-53373398d2c9

> Inspection records and compliance data for Piramal Pharma Limited in Pithampur. 9 FDA inspections on record, 1 Form 483, last inspected May 19, 2023.

---

## Details

- Name: Piramal Pharma Limited
- FEI Number: 3005259207
- Business Operations: FDF MANUFACTURE
- Address Line 1: Plot 67 - 70, Sector Ii; District Dhar
- City: Pithampur
- Country Name: India
- Address: Plot 67 - 70, Sector Ii; District Dhar, Pithampur, India
- Country: India

## Related Documents

- FDA Inspection 1208559 - Piramal Pharma Limited - 2023-05-19 — classification: No Action Indicated (NAI), source: FDA, date: May 19, 2023
- [FDA Inspection 1103288 - Piramal Pharma Limited - 2019-08-30](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/86b06f35-28c9-4f71-bae0-6fefd203f2c6) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2019
- FDA Inspection 1081925 - Piramal Pharma Limited - 2019-01-18 — classification: No Action Indicated (NAI), source: FDA, date: January 18, 2019
- [FDA Inspection 1005197 - Piramal Pharma Limited - 2017-02-21](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/4d5108d6-21cc-4fe9-b32e-d5c82096ac34) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2017
- FDA Inspection 951067 - Piramal Pharma Limited - 2015-10-30 — classification: No Action Indicated (NAI), source: FDA, date: October 30, 2015
- FDA Inspection 951067 - Piramal Pharma Limited - 2015-10-30 — classification: No Action Indicated (NAI), source: FDA, date: October 30, 2015
- [FDA Inspection 924411 - Piramal Pharma Limited - 2015-04-03](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/19284a5c-c477-4460-8928-1c97b042bde0) — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2015
- FDA Inspection 835339 - Piramal Pharma Limited - 2013-05-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2013
- FDA Inspection 760846 - Piramal Pharma Limited - 2011-12-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 21, 2011
- FDA Inspection 588995 - Piramal Pharma Limited - 2009-04-30 — classification: No Action Indicated (NAI), source: FDA, date: April 30, 2009

## Related Companies

- [Curia Massachusetts, Inc.](https://www.keypedia.com/companies/curia-massachusetts-inc/55538f85-da76-4bb1-b565-d4a6497a881e)
- [LTS Lohmann Therapy Systems Corp](https://www.keypedia.com/companies/lts-lohmann-therapy-systems-corp/8f67161c-919b-4a64-9e2e-4cc4b5ea9e52)
- [USAntibiotics LLC](https://www.keypedia.com/companies/usantibiotics-llc/05f8ab3c-a4d5-408f-9314-68ee8aa5e25a)
- [Aizant Drug Research Solutions Private Ltd.](https://www.keypedia.com/companies/aizant-drug-research-solutions-private-ltd/1a2d8dae-2eb4-4bc8-b36b-e94775bccd50)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/267a61e8-ff1e-4bcc-b3e3-9248535777f7)
- [Sidmak Laboratories India Pvt Ltd](https://www.keypedia.com/companies/sidmak-laboratories-india-pvt-ltd/2728534a-42a6-48f9-af65-6e6c302663a9)
- [JNTL Consumer Health (France) SAS](https://www.keypedia.com/companies/jntl-consumer-health-france-sas/316d5682-a2e5-4ac8-aba0-ef618c11aeb8)
- [ARNA Pharma Pty., Ltd.](https://www.keypedia.com/companies/arna-pharma-pty-ltd/e06145c8-ecf7-4bc1-9e0d-5aab8615b08f)
- [Patheon Softgels Inc.](https://www.keypedia.com/companies/patheon-softgels-inc/10cb6876-0398-4373-a33a-1d1e4c2bcf82)
- [Leading Pharma, LLC](https://www.keypedia.com/companies/leading-pharma-llc/9cbe169a-2e1b-4cdb-848c-209798a79db0)